• Bio-Works Technologies raised SEK 558,776 before issue costs from the exercise of 558,776 warrants of series TO 2.
• The eighth exercise period ran October 1-14, 2026, at a subscription price of SEK 1 per share.
• The exercise creates 558,776 new shares, bringing total shares to 100,972,656; dilution for nonparticipating shareholders is approximately 0.55%.
• Remaining unexercised TO 2 warrants total 15,966,714.
• The next exercise period runs January 4-18, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Works Technologies AB published the original content used to generate this news brief via Cision (Ref. ID: 20261015:BIT:4025:0) on October 15, 2026, and is solely responsible for the information contained therein.